VLS Valneva SE

VALNEVA Declaration of shares and voting rights: October 31, 2025

VALNEVA Declaration of shares and voting rights: October 31, 2025

VALNEVA

Declaration of shares and voting rights

October 31, 2025

__________________________________________________________________________________________

Company name: VALNEVA

Registered office: 6 rue Alain Bombard, 44800 Saint-Herblain (France)

Regulated market of Euronext Paris - Compartment B

Declaration date: November 5, 2025

Number of shares

composing the share capital of Valneva
Total number of voting rights including suspended voting rights*Description of the change Date on which this change was recognizedTotal number of voting rights excluding suspended voting rights**
 171,958,275



ordinary shares with a par value of €0.15 each
187,846,678Transfer into bearer form of 235,387 shares with double voting rights

 Definitive attribution of 103,419 free ordinary shares
Between October 3 & October 30, 2025









On October 10, 2025
187,722,356

___________________________

* Theoretical voting rights. This number is used as the basis for calculating threshold crossings. In accordance with Article 223-11 of the AMF General Regulations, this number is calculated on the basis of all shares to which voting rights are attached, including those for which voting rights have been suspended.

** Net (or exercisable at a General Meeting) voting rights.

Attachment



EN
05/11/2025

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Valneva SE

 PRESS RELEASE

Valneva to Participate in Multiple Events at the 26th World Vaccine C...

Valneva to Participate in Multiple Events at the 26th World Vaccine Congress in Washington DC Lyon (France), March 26, 2026 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced its participation in the upcoming 26th World Vaccine Congress, which will take place from March 31 to April 2, 2026 at the Walter E. convention center in Washington, D.C. Led by the Company´s Chief Executive Officer, Thomas Lingelbach, a team of Valneva´s senior executives will participate in multiple events throughout the conference. On April 1, 2026, at 9:40 am EST, Susan...

 PRESS RELEASE

Valneva participera à plusieurs événements lors du 25ème World Vaccin...

Valneva participera à plusieurs événements lors du 25ème World Vaccine Congress de Washington Lyon (France), le 26 mars 2026 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), société spécialisée dans les vaccins a annoncé aujourd'hui sa présence au 26ème World Vaccine Congress, qui se tiendra du 31 mars au 2 avril 2026 au Walter E. Convention Center à Washington, D.C. Sous la direction du directeur général de la Société, Thomas Lingelbach, des membres de l’équipe dirigeante de Valneva participeront à différents événements, durant le congrès. Le 1er avril 2026 à 14h40 (9h40 EST), Susanne E...

Martial Descoutures
  • Martial Descoutures

ResearchPool Subscriptions

Get the most out of your insights

Get in touch